Search research articles
Contact Us
Filters
Showing results (301-310 of 481) with videos related to
Page
of 49
Sort By:
The Journal of Clinical Investigation
|
June 22, 2021
Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface
Seth J Zost, Jinhui Dong, Iuliia M Gilchuk, et al.
Plos Pathogens
|
December 11, 2024
Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression
Marloes Grobben, Margreet Bakker, Angela I Schriek, et al.
Biorxiv : the Preprint Server for Biology
|
June 29, 2026
Translating Innovation to Clinic: End-to-End Bioprocess Development and cGMP Manufacturing of N332-GT5 HIV Vaccine Candidate for First-in-Human Trials HVTN144
Sammaiah Pallerla, Shaunak Uplekar, Ferenc Boldog, et al.
Iscience
|
August 16, 2022
Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways
Fangzhu Zhao, Celina Keating, Gabriel Ozorowski, et al.
Plos Pathogens
|
September 27, 2013
A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies
Rogier W Sanders, Ronald Derking, Albert Cupo, et al.
Nature Communications
|
December 11, 2025
Structural and immunological characterization of the H3 influenza hemagglutinin during antigenic drift
Rebeca de Paiva Froes Rocha, Ilhan Tomris, Charles A Bowman, et al.
Cell
|
June 5, 2026
Replaying germinal center evolution on a quantified affinity landscape
William S DeWitt, Ashni A Vora, Tatsuya Araki, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2025
Replaying germinal center evolution on a quantified affinity landscape
William S DeWitt, Ashni A Vora, Tatsuya Araki, et al.
Plos Pathogens
|
August 25, 2021
Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates
Jelle van Schooten, Marlies M van Haaren, Hui Li, et al.
Nature Microbiology
|
May 9, 2018
Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region
Andrew I Flyak, Natalia Kuzmina, Charles D Murin, et al.
Page
of 49
Search research articles
Search
Showing results (301-310 of 481) with videos related to
Sort By:
Page
of 49
The Journal of Clinical Investigation
|
June 22, 2021
Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface
Seth J Zost, Jinhui Dong, Iuliia M Gilchuk, et al.
Plos Pathogens
|
December 11, 2024
Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression
Marloes Grobben, Margreet Bakker, Angela I Schriek, et al.
Biorxiv : the Preprint Server for Biology
|
June 29, 2026
Translating Innovation to Clinic: End-to-End Bioprocess Development and cGMP Manufacturing of N332-GT5 HIV Vaccine Candidate for First-in-Human Trials HVTN144
Sammaiah Pallerla, Shaunak Uplekar, Ferenc Boldog, et al.
Iscience
|
August 16, 2022
Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways
Fangzhu Zhao, Celina Keating, Gabriel Ozorowski, et al.
Plos Pathogens
|
September 27, 2013
A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies
Rogier W Sanders, Ronald Derking, Albert Cupo, et al.
Nature Communications
|
December 11, 2025
Structural and immunological characterization of the H3 influenza hemagglutinin during antigenic drift
Rebeca de Paiva Froes Rocha, Ilhan Tomris, Charles A Bowman, et al.
Cell
|
June 5, 2026
Replaying germinal center evolution on a quantified affinity landscape
William S DeWitt, Ashni A Vora, Tatsuya Araki, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2025
Replaying germinal center evolution on a quantified affinity landscape
William S DeWitt, Ashni A Vora, Tatsuya Araki, et al.
Plos Pathogens
|
August 25, 2021
Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates
Jelle van Schooten, Marlies M van Haaren, Hui Li, et al.
Nature Microbiology
|
May 9, 2018
Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region
Andrew I Flyak, Natalia Kuzmina, Charles D Murin, et al.
Page
of 49